Down-regulation of spinophilin in lung tumours contributes to tumourigenesis

Journal of Pathology

Volumn 225, Issue 1, 2011, Pages 73-82

  Molina Pinelo, Sonia ^a   Ferrer, Irene ^b   Blanco Aparicio, Carmen ^b   Peregrino, Sandra ^b   Pastor, Maria Dolores ^a   Alvarez Vega, Juan ^a   Suarez, Rocio ^a   Verge, Mar ^a   Marin, Juan J ^a,c   Hernandez Losa, Javier ^d   Cajal, Santiago Ramon ^d   Paz Ares, Luis ^a   Carnero, Amancio ^a  

^a Instituto de Biomedicina de Sevilla   (Spain)

^b Structural Biology and Biocomputing Programme   (Spain)

^c UNIVERSITY OF SEVILLE   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

lung tumours; p53; PPP1R9B; spinophilin; tumour suppressor

Indexed keywords

MICRORNA; PROTEIN P53; SPINOPHILIN;

ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG TUMOR; MUTATION; PRIORITY JOURNAL; RNA ANALYSIS; TUMOR CELL;

CARCINOMA, NON-SMALL-CELL LUNG; CELL TRANSFORMATION, NEOPLASTIC; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG; LUNG NEOPLASMS; MICROFILAMENT PROTEINS; MICRORNAS; NEOPLASM PROTEINS; NERVE TISSUE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79960923813     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2905     Document Type: Article

References (26)

1. Allen PB, Ouimet CC, Greengard P,. Spinophilin, a novel protein phosphatase 1 binding protein localized to dendritic spines. Proc Natl Acad Sci USA 1997; 94: 9956-9961. (Pubitemid 27408172)
2. Satoh A, Nakanishi H, Obaishi H, et al., Neurabin-II/spinophilin. An actin filament-binding protein with one pdz domain localized at cadherin-based cell-cell adhesion sites. J Biol Chem 1998; 273: 3470-3475. (Pubitemid 28109767)
3. Sarrouilhe D, di Tommaso A, Metaye T, et al., Spinophilin: from partners to functions. Biochimie 2006; 88: 1099-1113.
4. Vivo M, Calogero RA, Sansone F, et al., The human tumor suppressor arf interacts with spinophilin/neurabin II, a type 1 protein-phosphatase-binding protein. J Biol Chem 2001; 276: 14161-14169.
5. Feng J, Yan Z, Ferreira A, et al., Spinophilin regulates the formation and function of dendritic spines. Proc Natl Acad Sci USA 2000; 97: 9287-9292. (Pubitemid 30626711)
6. Tsukada M, Prokscha A, Eichele G, Neurabin II mediates doublecortin-dephosphorylation on actin filaments. Biochem Biophys Res Commun 2006; 343: 839-847.
7. Bielas SL, Serneo FF, Chechlacz M, et al., Spinophilin facilitates dephosphorylation of doublecortin by PP1 to mediate microtubule bundling at the axonal wrist. Cell 2007; 129: 579-591. (Pubitemid 46660968)
8. Querzoli P, Albonico G, di Iasio MG, et al., Biophenotypes and survival of BRCA1- and TP53-deleted breast cancer in young women. Breast Cancer Res Treat 2001; 66: 135-142. (Pubitemid 32521419)
9. Caduff RF, Svoboda-Newman SM, Ferguson AW, et al., Comparison of alterations of chromosome 17 in carcinoma of the ovary and of the breast. Virchows Arch 1999; 434: 517-522. (Pubitemid 29281309)
10. Maitra A, Tavassoli FA, Albores-Saavedra J, et al., Molecular abnormalities associated with secretory carcinomas of the breast. Hum Pathol 1999; 30: 1435-1440. (Pubitemid 30032919)
11. Porter DE, Steel CM, Cohen BB, et al., Genetic linkage analysis applied to unaffected women from families with breast cancer can discriminate high- from low-risk individuals. Br J Surg 1993; 80: 1381-1385. (Pubitemid 23345092)
12. Porter DE, Cohen BB, Wallace MR, et al., Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12-21. Br J Surg 1994; 81: 1512-1515. (Pubitemid 24306008)
13. Cohen BB, Porter DE, Wallace MR, et al., Linkage of a major breast cancer gene to chromosome 17q12-21: results from 15 Edinburgh families. Am J Hum Genet 1993; 52: 723-729. (Pubitemid 23310139)
14. Smith SA, Easton DF, Ford D, et al., Genetic heterogeneity and localization of a familial breast-ovarian cancer gene on chromosome 17q12-q21. Am J Hum Genet 1993; 52: 767-776. (Pubitemid 23310146)
15. Easton DF, Bishop DT, Ford D, et al., Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet 1993; 52: 678-701. (Pubitemid 23310135)
16. Abujiang P, Mori TJ, Takahashi T, et al., Loss of heterozygosity (LOH) at 17q and 14q in human lung cancers. Oncogene 1998; 17: 3029-3033. (Pubitemid 29012206)
17. Carnero A, Hudson JD, Hannon GJ, et al., Loss-of-function genetics in mammalian cells: the p53 tumor suppressor model. Nucleic Acids Res 2000; 28: 2234-2241. (Pubitemid 30639356)
18. Ruiz L, Traskine M, Ferrer I, et al., Characterization of the p53 response to oncogene-induced senescence. PLoS ONE 2008; 3: e3230.
19. Guijarro MV, Leal JF, Blanco-Aparicio C, et al., MAP17 enhances the malignant behavior of tumor cells through ROS increase. Carcinogenesis 2007; 28: 2096-2104. (Pubitemid 47543368)
20. Castro ME, Ferrer I, Cascon A, et al., PPP1CA contributes to the senescence program induced by oncogenic Ras. Carcinogenesis 2008; 29: 491-499. (Pubitemid 351404864)
21. Blanco-Aparicio C, Perez-Gallego L, Pequeno B, et al., Mice expressing myrAKT1 in the mammary gland develop carcinogen-induced ER-positive mammary tumors that mimic human breast cancer. Carcinogenesis 2007; 28: 584-594. (Pubitemid 46523354)
22. Campisi J, d'Adda di Fagagna F, Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007; 8: 729-740. (Pubitemid 47312822)
23. Collado M, Serrano M, The power and the promise of oncogene-induced senescence markers. Nat Rev Cancer 2006; 6: 472-476.
24. Tseng SL, Yu IC, Yue CT, et al., Allelic loss at BRCA1, BRCA2, and adjacent loci in relation to TP53 abnormality in breast cancer. Genes Chromosomes Cancer 1997; 20: 377-382.
25. Hellemans J, Mortier G, De Paepe A, et al., qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol. 2007; 8 (2): R19.
26. Ferrer I, Peregrino S, Canamero M, et al., Spinophilin loss contributes to tumorigenesis in vivo. cell Cycle. 2011; In press.